Oct 9, 2026 · 3 min listen · Last updated October 9, 2026
From storyflo. This is your daily audio brief. It's Chloe, October 9th. Ten stories — evidence-led, no fluff, small inputs compound. Let's get into it. First, from Dan Harris. Calm Your Nervous System: Simple Daily Practices for When You're Wired, Hangry, or Too Busy to Rest | Nadia Narain & Katia Narain Phillips.
Listen · storyflo · health and longevity
Daily Health & Wellness Brief · October 9th
0:00-3:03
Pick your daily storyteller
Subscribe to match with Theo, Jessica, Chloe, Mason, Brock — your voice, every brief.
Daily Health & Wellness Brief · October 9th · Storyflo
culture
Audio pre-rendered by Storyflo · cached + delivered from the edge
Calm Your Nervous System: Simple Daily Practices for When You're Wired, Hangry, or Too Busy to Rest | Nadia Narain & Katia Narain Phillips
In this episode, Nadia Narain and Katia Narain Phillips explore the idea that staying calm all the time isn't the ultimate goal. They discuss how our perceptions of rest can be misleading, often leading us to overlook the small, joyful moments—what they call "glimmers." These glimmers can actually spread positivity, making them contagious in our daily lives.
They share a unique perspective on stress, including a simple trick to release tension we might not even realize we're holding. Interestingly, they touch on what animals can teach us about managing stress, emphasizing the importance of our field of vision and how it interacts with our nervous system.
The conversation also highlights how everyday chores can serve as a form of meditation, and how rushing can derail our best intentions. Leaving dishes in the sink, for instance, might not be a failure but rather a step toward progress. They remind us that rest is personal and varies from person to person, encouraging listeners to consider what reparenting themselves might look like in their own lives.
You Could Do Anything. So Why Are You Doing Nothing?
It’s late, and you find yourself scrolling through endless tabs—courses you’ve bought but never started, job postings you’re almost qualified for, and old journal entries echoing your struggle to focus. This scenario is more common than you might think, and it doesn’t mean you’re lazy or broken. It’s about a disconnect between your capabilities and your motivation.
You have the capacity to do so much, but sometimes that doesn’t translate into action. The pressure to make the “right” choice can leave you stuck in a cycle of research instead of taking steps forward. Understanding this mismatch is crucial. You’re not alone in feeling overwhelmed by possibilities; it’s a challenge many face. Recognizing that capacity doesn’t always equal direction can help you move past the paralysis of choice and start taking small, manageable steps toward what you want to achieve.
Bonnie sent over Grandma Dorothy’s mahjong set, and it arrived in perfect condition, which is such a nice connection to family. Then, there were these incredible fireworks outside my window tonight, and honestly, I have no idea what the occasion was, but it felt like a little surprise celebration. And guess what? My favorite crunchy peanut butter was back in stock at the market today, which always makes my day better.
How about you? What are three good things that happened to you recently? I’d love to hear!
They’ve shared the first round of tour dates and are eager to connect with fans through book signings, photos, and conversations. Some tour stops will even feature tastings of recipes from the book, which sounds like a fun way to engage. If you're interested, check the tour page for specific details and ticket information for your city. It’s a great opportunity to meet the author and experience the cookbook firsthand. They’re genuinely excited to see everyone!
TRexBio prices $117M IPO for Tregs as Retension lands $45M Nasdaq debut for hypertension
TRexBio has successfully priced its initial public offering at $117 million, focusing on T regulatory cells, or Tregs, which are crucial for immune response regulation. This move signals increasing investor interest in innovative therapies that target immune system modulation. The IPO is a significant step for the company as it aims to advance its research and development efforts in this promising area.
Meanwhile, Retension made its debut on Nasdaq, raising $45 million to tackle hypertension. This funding will support their efforts in developing new treatments for high blood pressure, a condition that affects millions. Both companies reflect a growing trend in biotech, where investors are keen on supporting novel approaches to longstanding health issues.
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to storyflo · health and longevity.